About
Susan Uptain, Ph.D. is a biopharma executive focused on program leadership, regulatory strategy, and drug development. As Head of Project Team Leadership and Regulatory at Calico, she helps advance therapies targeting aging and age-related diseases from candidate nomination through IND filing and clinical proof of concept. Earlier public sources place her in senior regulatory and program roles at Xilio Therapeutics, Takeda, Shire, Baxalta, and Merck.
Areas of interest
longevitybiotechdrug developmentregulatory affairsagingage-related diseasesquality managementimmuno-oncology